Loading...
•
Sep 30, 2024
Conmed Q3 2024 Earnings Report
CONMED's third quarter results were announced, revealing a sales increase of 4.0% year-over-year and GAAP diluted net earnings per share of $1.57.
Key Takeaways
CONMED Corporation reported its third quarter 2024 financial results, with sales increasing by 4.0% year-over-year to $316.7 million. The company's GAAP diluted net earnings per share was $1.57, and adjusted diluted net earnings per share was $1.05, a 16.7% increase compared to the third quarter of 2023.
Sales increased 4.0% year-over-year, reaching $316.7 million.
GAAP diluted net earnings per share was $1.57, compared to $0.50 in Q3 2023.
Adjusted diluted net earnings per share increased 16.7% to $1.05.
COO Patrick Beyer will succeed Curt Hartman as President and CEO effective January 1, 2025.
Revenue by Segment
Forward Guidance
Full year reported revenue is now expected to be between $1.300 billion and $1.305 billion. The Company now expects full-year adjusted diluted net earnings per share in the range of $4.00 to $4.05.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...